Methacrylic Acid
CAS 79-41-4
Methacrylic Acid (CAS 79-41-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| METHACRYLIC ACID | 1424905 | SU | MTHSPL |
| Methacrylic Acid | 1424905 | SU | MTHSPL |
| methacrylic acid | 1424905 | SU | MTHSPL |
| methacrylic acid | 1424905 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Methacrylic Acid used for in pharmaceutical contexts?
Methacrylic Acid (CAS 79-41-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Methacrylic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Methacrylic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Methacrylic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Methacrylic Acid with EU status "prohibited".
What clinical phase is Methacrylic Acid in?
No phase 1-4 clinical development badge is rendered for Methacrylic Acid because the matched compound identifier rows do not contain a max-phase value.